MARKET

SERA

SERA

Sera Prognostics, Inc.
NASDAQ
3.000
+0.050
+1.69%
After Hours: 3.000 0 0.00% 16:10 01/02 EST
OPEN
2.970
PREV CLOSE
2.950
HIGH
3.015
LOW
2.860
VOLUME
26.02K
TURNOVER
--
52 WEEK HIGH
8.73
52 WEEK LOW
1.370
MARKET CAP
115.78M
P/E (TTM)
-3.8981
1D
5D
1M
3M
1Y
5Y
1D
Sera Prognostics Inc. Chief Information Officer Robert Gardner Reports Disposal of Common Shares
Reuters · 12/30/2025 23:41
Tuesday Sector Laggards: Sporting Goods & Activities, Biotechnology Stocks
NASDAQ · 12/30/2025 17:26
Weekly Report: what happened at SERA last week (1222-1226)?
Weekly Report · 12/29/2025 10:05
Weekly Report: what happened at SERA last week (1215-1219)?
Weekly Report · 12/22/2025 10:05
Tracking Baker Brothers Portfolio - Q3 2025 Update
Seeking Alpha · 12/16/2025 14:19
Weekly Report: what happened at SERA last week (1208-1212)?
Weekly Report · 12/15/2025 10:10
U.S. RESEARCH ROUNDUP-Applied Materials, Coca-Cola, Glacier Bancorp
Reuters · 12/15/2025 08:11
SERA PROGNOSTICS INC <SERA.O>: JEFFERIES INITIATES COVERAGE WITH BUY RATING; TARGET PRICE $5
Reuters · 12/15/2025 06:20
More
About SERA
Sera Prognostics, Inc. is a women's health diagnostic company utilizing its proprietary proteomics and bioinformatics platform, and significant data resources to enhance maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are accurate predictors of dynamic changes that occur during pregnancy. Its commercial product, the PreTRM test, is a validated, commercially available blood-based biomarker test to predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation that provides a prediction of the expectant mother’s risk of delivering spontaneously before 37 weeks’ gestation.

Webull offers Sera Prognostics Inc stock information, including NASDAQ: SERA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SERA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SERA stock methods without spending real money on the virtual paper trading platform.